Loading stock data…
$3.01-0.09 (-2.90%)
Autonomix Medical, Inc., a development stage medical device company, focuses on advancing technologies for sensing and treating disorders of nervous system.
Autonomix Medical, Inc. in the Healthcare sector is trading at $3.01 with a market capitalization of $4M. Wall Street consensus targets $58.80 (2 analysts), implying a +1853.5% move over the next 12 months. The stock is currently near its 52-week low of $2.44, remaining 59.0% below its 200-day moving average. On fundamentals, Piotroski 3/9 flags weak fundamentals, Altman Z in the distress zone. Risk note: RSI 17 is oversold, raising the odds of a near-term bounce; MACD remains below its signal line. The Whystock Score of 35/100 signals elevated caution as multiple indicators diverge.
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $0 | $0 | $0 | $0 | $0 |
| Gross Profit | — | — | — | — | — |
| Operating Income | -$2.77M↓ | -$2.74M↑ | -$3.34M↑ | -$7.53M↓ | -$3.42M |
| Net Income | -$2.73M↓ | -$2.67M↑ | -$3.26M↑ | -$7.45M↓ | -$3.34M |
Autonomix Medical, Inc., a development stage medical device company, focuses on advancing technologies for sensing and treating disorders of nervous system. The company's technology platform includes a catheter-based system incorporating microchip-en...